SEI Investments’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
MCMU
SEI Investments's RXRX Position: Q2 2026 in Review
SEI Investments held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 50,448 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #3060.
SEI Investments first reported a position in RXRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $247K in Q3 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.
- SEI Investments held 50,448 shares of Recursion Pharmaceuticals worth $185K as of Q2 2026.
- SEI Investments left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3060 holding.
- SEI Investments first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
- SEI Investments's Recursion Pharmaceuticals position peaked at $247K in Q3 2025.
- 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.